153 related articles for article (PubMed ID: 17215638)
1. Contemporary diagnosis and management of hypercholesterolemia in elderly acute myocardial infarction patients: a population-based study.
Berger AK; Duval SJ; Armstrong C; Jacobs DR; Luepker RV
Am J Geriatr Cardiol; 2007; 16(1):15-23. PubMed ID: 17215638
[TBL] [Abstract][Full Text] [Related]
2. Lipid attainment among patients newly treated with lipid-altering drugs.
Hess G; Chang CL; Chung K
Curr Med Res Opin; 2014 Sep; 30(9):1743-56. PubMed ID: 24889282
[TBL] [Abstract][Full Text] [Related]
3. A community-wide survey of physician practices and attitudes toward cholesterol management in patients with recent acute myocardial infarction.
Yarzebski J; Bujor CF; Goldberg RJ; Spencer F; Lessard D; Gore JM
Arch Intern Med; 2002 Apr; 162(7):797-804. PubMed ID: 11926854
[TBL] [Abstract][Full Text] [Related]
4. Changes in the management of acute myocardial infarction in Southern Tasmania.
McNamara KS; Peterson GM; Friesen WT
J Clin Pharm Ther; 2000 Apr; 25(2):111-8. PubMed ID: 10849188
[TBL] [Abstract][Full Text] [Related]
5. Clinical Impact of Rapid Reduction of Low-Density Lipoprotein Cholesterol Level on Long-Term Outcome of Acute Myocardial Infarction in the Statin Era: Subanalysis of the ALPS-AMI Study.
Miura T; Izawa A; Motoki H; Miyashita Y; Kashima Y; Ebisawa S; Tomita T; Koyama J; Ikeda U
PLoS One; 2015; 10(6):e0127835. PubMed ID: 26083546
[TBL] [Abstract][Full Text] [Related]
6. Changing trends (1986-2003) in the use of lipid lowering medication in patients hospitalized with acute myocardial infarction: a community-based perspective.
Yarzebski J; Granillo E; Spencer FA; Lessard D; Gurwitz JH; Gore JM; Goldberg RJ
Int J Cardiol; 2009 Feb; 132(1):66-74. PubMed ID: 18201781
[TBL] [Abstract][Full Text] [Related]
7. Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey.
Krempf M; Simpson RJ; Ramey DR; Brudi P; Giezek H; Tomassini JE; Lee R; Farnier M
Lipids Health Dis; 2015 May; 14():45. PubMed ID: 25985907
[TBL] [Abstract][Full Text] [Related]
8. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in lipid profiles and treatment utilization among young adults with acute myocardial infarction: Results from the VIRGO study.
Lu Y; Zhou S; Dreyer RP; Caulfield M; Spatz ES; Geda M; Lorenze NP; Herbert P; D'Onofrio G; Jackson EA; Lichtman JH; Bueno H; Spertus JA; Krumholz HM
Am Heart J; 2017 Jan; 183():74-84. PubMed ID: 27979045
[TBL] [Abstract][Full Text] [Related]
10. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.
Sahebkar A; Watts GF
Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550
[TBL] [Abstract][Full Text] [Related]
11. Achieving optimal lipid goals in patients with coronary artery disease.
Karalis DG; Subramanya RD; Hessen SE; Liu L; Victor MF
Am J Cardiol; 2011 Mar; 107(6):886-90. PubMed ID: 21247526
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol levels and statin use in patients with coronary heart disease treated in primary care settings.
O'Connor PJ; Gray RJ; Maciosek MV; Fillbrandt KM; DeFor TA; Alexander CM; Weiss TW; Teutsch SM
Prev Chronic Dis; 2005 Jul; 2(3):A05. PubMed ID: 15963307
[TBL] [Abstract][Full Text] [Related]
13. The statin era: in search of the ideal lipid regulating agent.
Shepherd J
Heart; 2001 Mar; 85(3):259-64. PubMed ID: 11179260
[No Abstract] [Full Text] [Related]
14. Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy.
Hunninghake DB
Am J Med; 1998 Feb; 104(2A):9S-13S. PubMed ID: 9550501
[TBL] [Abstract][Full Text] [Related]
15. The benefit of fibrates in the treatment of 'bad HDL-C responders to statins'.
Devroey D; Velkeniers B; Duquet W; Betz W
Int J Cardiol; 2005 May; 101(2):231-5. PubMed ID: 15882669
[TBL] [Abstract][Full Text] [Related]
16. [Effect of cholesterol reducing therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on secondary prevention after myocardial infarction in Japanese patients].
Tachibana E; Watanabe I; Nagao K; Kanmatsuse K
J Cardiol; 2000 Apr; 35(4):277-85. PubMed ID: 10791271
[TBL] [Abstract][Full Text] [Related]
17. [Lipid-lowering therapy and patient adherence in the MULTI GAP 2013 trial].
Simonyi G
Orv Hetil; 2014 Apr; 155(17):669-75. PubMed ID: 24755449
[TBL] [Abstract][Full Text] [Related]
18. Incidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug.
Aronow WS; Ahn C
Am J Cardiol; 2002 Jan; 89(1):67-9. PubMed ID: 11779527
[No Abstract] [Full Text] [Related]
19. Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl.
Spencer FA; Goldberg RJ; Gore JM; Fox KA; Avezum A; Agnelli G; Kritharides L; Anderson FA; Goodman SG; FitzGerald G; Allegrone J; Brieger D;
Am J Cardiol; 2007 Sep; 100(6):913-8. PubMed ID: 17826369
[TBL] [Abstract][Full Text] [Related]
20. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
Evans M; Roberts A; Davies S; Rees A
Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
